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ABSTRACT
Hepatitis C virus (HCV) is a human RNA virus encod-
ing 10 proteins in a single open reading frame. In
the +1 frame, an ‘alternate reading frame’ (ARF)
overlaps with the core protein-encoding sequence
and encodes the ARF protein (ARFP). Here, we
investigated the molecular regulatory mechanisms
of ARFP expression in HCV target cells. Chimeric
HCV-luciferase reporter constructs derived from the
infectious HCV prototype isolate H77 were trans-
fected into hepatocyte-derived cell lines. Translation
initiation was most efficient at the internal AUG
codon at position 86/88, resulting in the synthesis of
a truncated ARFP named 86/88ARFP. Interestingly,
86/88ARFP synthesis was markedly enhanced in
constructs containing an inactivated core protein
reading frame. This enhancement was reversed by
co-expression of core protein in trans, demonstrat-
ing suppression of ARFP synthesis by HCV core
protein. In conclusion, our results indicate that
translation of ARFP occurs mainly by alternative
internal initiation at position 86/88 and is regulated
by HCV core protein expression. The suppression of
ARFP translation by HCV core protein suggests that
ARFP expression is inversely linked to the level of
viral replication. These findings define key mecha-
nisms regulating ARFP expression and set the stage
for further studies addressing the function of ARFP
within the viral life cycle.
INTRODUCTION
More than 170 million people worldwide are currently
infected with the hepatitis C virus (HCV). HCV infection
represents a major cause of chronic liver disease and
hepatocellular carcinoma (1). HCV is an enveloped virus
belonging to the Flaviviridae family and is the unique
member of the hepacivirus genus. The HCV genome is
a single-stranded positive RNA of about 9.6kb. The 50
untranslated region (UTR) forms an internal ribosome
entry site (IRES) that directs the translation of a precursor
polyprotein of about 3000 amino acids. This polyprotein
is cleaved co- and post-translationally by cellular and viral
proteases, resulting in the synthesis of both structural and
non-structural (NS) proteins. The structural proteins core,
E1 and E2 are processed by host signal peptidases. The
core protein presumably forms the viral nucleocapsid (2),
whereas E1 and E2 are glycoproteins anchored in the viral
envelope (3). The NS proteins NS2, NS3, NS4A, NS4B,
NS5A and NS5B are essential for replication of the viral
genome (4). The 30 UTR is a highly conserved and struc-
tured region playing a key role in the initiation and
regulation of viral replication.
Besides the polyprotein open reading frame, sequence
analyses have shown the existence of an alternate reading
frame (ARF) overlapping with the core protein encoding
sequence in the +1 frame (5). Xu et al. (6) have suggested
that this overlapping reading frame encodes a 17kDa pro-
tein. This protein is named ‘F’ (for frameshift) or ‘ARFP’
[for Alternate ReadingFrame Protein (7)]. Previous studies
have suggested that ARFP’s synthesis results from a +1
ribosomal frameshifting event near codon 11. This event
occurs after initiation at the AUG initiator codon of the
polyprotein (6). ARFP’s existence is supported by a high
conservation of its open reading frame (ORF) in all
genotypes. Furthermore, peptides corresponding to this
+1 reading frame react with antiviral antibodies present in
the sera from HCV-infected patients. These ﬁndings
suggest that ARFP is synthesized in vivo and its synthesis
results in the induction of anti-ARFP immune responses
(8,9). The function of the ARFP is currently unknown.
Following translation, the protein is localized to the
endoplasmic reticulum (10,11).
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frequent in viral translation (12,13), and is used in partic-
ular by viruses to express a maximum of information
through a limited genome. Several studies [reviewed by
Giedroc et al. (14)], have mapped the optimal context
required to direct a  1 ribosomal frameshifting event.
These include a sequence formed by redundant runs of
bases, coupled with a stem-loop often folded in a pseudo-
knot conformation. In this context, the presence of strong
RNA structures most likely results in the induction of a
ribosomal pause during translation and induces a ribo-
somal shift from its initial reading frame to the overlapping
frame.
In contrast, mechanisms responsible for +1 ribosomal
frameshifting can depend on the stability of the ribosome–
RNA interaction and on speciﬁc RNA structures (15,16).
The bacterial RF2 gene (17), the yeast TY1 and TY3
retrotransposones (18,19) and the eukaryotic antizyme (20)
are well-characterized examples of the proteins synthesized
by +1 ribosomal frameshifting.
The occurrence of a ribosomal frameshifting event
during HCV translation, ﬁrst described by Xu et al. (6),
is controversial, since the sequence used to demonstrate
the +1 ribosomal frameshift contains a unique 10 adenine
stretch at the beginning of the core protein sequence.
As suggested by Xu et al. (6), this adenine stretch could
account for ribosomal pausing. On the other hand,
sequences composed of consecutive adenines have been
shown to support transcriptional slippage by inducing
RNA polymerase stuttering. Stuttering may lead to modi-
ﬁcation of the ﬁnal protein amino acid sequence through
the insertion of non-template nucleotides during RNA
synthesis (21,22). Moreover, alternative translation mecha-
nisms of the overlapping reading frame have been
proposed. These include initiation of translation at diﬀer-
ent sites resulting in the synthesis of shorter forms of the
ARFP. Baril and Brakier-Gingras (23) have proposed that
codon 26 is recognized by ribosomes as a site of non-AUG
translation initiation in HCV genotype 1a isolates. On the
other hand, Vassilaki and Mavromara (24) have shown
that translation of the +1 frame can initiate on an AUG
codon at position 86 or 88 of the polyprotein. The rele-
vance of these mechanisms in translation of functional
infectious HCV isolates in target cells of HCV infection is
unknown. The ARFP products, presumably resulting from
these translation mechanisms, have been named fARFP,
26ARFP and, 86/88ARFP for ribosomal frameshifting,
initiation at codon 26, and initiation at codon 86/88,
respectively. Furthermore, mechanisms of regulation of
ARFP expression are not understood.
To deﬁne the molecular mechanisms of ARFP expres-
sion, we transfected chimeric HCV-H77-luciferase con-
structs into Huh-7 cells. We demonstrate that initiation
of ARFP translation occurs mainly at position 86/88
and is regulated by HCV core protein expression.
Furthermore, we show that ARFP translation is down-
regulated by HCV core protein. Thus, ARFP expression is
inversely linked to the level of viral replication which may
explain the low-level expression of ARFP during viral
infection.
MATERIALS AND METHODS
Cellculture andtransfection
The human hepatoma cell line Huh-7 was kindly pro-
vided by R. Bartenschlager (University of Heidelberg,
Germany). Embryonic kidney cells (HEK 293) were
obtained from American Type Culture Collection
(ATCC). The cells were grown and transfected as pre-
viously described (25). Medium, fetal calf serum and cell
culture additives were purchased from Gibco-BRL.
HCV H77luciferase reporter constructs
A schematic outline of the plasmids is shown in Figure 1.
Nucleotide numbering refers to the HCV H77 genome
sequence (genotype 1a) encoded by p90/HCV FL-long pU
(26). This plasmid was used as a template for DNA
ampliﬁcations. Plasmid pIV1066 was obtained by inserting
the luciferase gene of pBI-L (Clontech) into the EcoRI-
XbaI sites of a pCIneo plasmid vector (Promega). The ﬁrst
nine nucleotides (including the ATG) of the luciferase gene
were deleted by PCR, and the resulting fragment was
cloned into the EcoRI-XbaI sites of pCIneo. The resulting
plasmid was named pIV1115. For plasmids pIV1143 to
1147, and pIV1157, fragments of the HCV core protein
encoding sequence (with or without 50 UTR) were
ampliﬁed by PCR using p90/HCV FL-long pU as a
template. The ampliﬁed fragments obtained were then
ligated into the EcoRI site of pIV1115. Plasmids pIV1143,
pIV1144 and pIV1157 include the 50 UTR and nucleotides
(nts) 342–822 of the core protein sequence. This sequence
was fused in the 0, +1 or  1frame with the luciferase gene.
pIV1145, pIV1146 and pIV1147 are the corresponding
plasmids without 50 UTR. Plasmids pIV1204 and pIV1206
contain a single nucleotide substitution at nt 399 of the
HCV H77 sequence introduced by the QuickChange
Site-directed Mutagenesis Kit (Stratagene) into plasmids
pIV1144 and pIV1146. This substitution leads to a stop
codon in the core protein sequence (0 frame) (Q20!TAG)
without aﬀecting the ARFP amino acidsequence. Plasmids
pIV1203 and pIV1240 contain a single nucleotide sub-
stitution at nt 407 of the HCV H77 sequence introduced
by the QuickChange Site-directed Mutagenesis Kit
(Stratagene) into plasmids pIV1143 and pIV1144. This
substitution leads to a stop codon in the ARFP protein
sequence (+1 frame) (S22!TGA) without aﬀecting the
core amino acid sequence. For plasmids pIV1242 to
pIV1247, an XbaI - SalI restriction fragment encoding
the 30 UTR of HCV (nts 9204–9651) was ampliﬁed by
PCR. This PCR product was added to the 30 end of the
luciferase gene sequence in all previous plasmid sequences.
RT–PCR analysis of transcripts derived from
HCV-luc constructs
Huh-7 cells were transfected with chimeric HCV-luc
expression constructs as described earlier. Total RNA
was isolated using the RNeasy kit (Qiagen). Reverse
transcription was performed using 5mg of puriﬁed total
cellular RNA, SuperScript III reverse transcriptase
(Invitrogen), and random primers (Invitrogen), following
the manufacturer’s recommendations. Subsequent PCR
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DNA Polymerase (Invitrogen), a reverse primer corre-
sponding to the 30 region of the luciferase gene (Reverse 1,
50CCTCTAGAACTAGTGGATCCCCCC30) and a for-
ward primer corresponding to the HCV 50UTR (nts 1–15)
for IRES-containing constructs (Forward 1, 50GGAA
TTCGCAGCCCCCTGATG30) or to the 50 region of the
core protein encoding sequence (nts 342–362) for con-
structs lacking IRES (Forward 2, 50GGAATTCATGA
GCACGAATCCTAAACCT30). PCR products were then
separated on a 1% agarose gel.
Recombinant adenovirus vectors
Recombinant adenoviral genomes were generated as infec-
tious plasmids by homologous recombination in E. coli as
previously described (27). Brieﬂy, a DNA fragment encod-
ing the full-length core protein (nts 342–914) was obtained
by PCR using p90/HCV FL-long pU as a template, and
was inserted into the EcoRI-XbaI sites of the adenoviral
shuttle plasmid pTG13337. The resulting vector, pIV1210,
was used for homologous recombination with adenoviral
sequences of the backbone vector pTG6624 (27), resulting
Figure 1. Design of core-luciferase and ARFP-luciferase expression constructs. (A) Schematic outline of the HCV genome. HCV (core/ARFP)
potential translation initiation sites are indicated. Numbers correspond to respective codons. (B) Schematic outline of the plasmid constructs. Plasmid
constructs contain the core/ARFP sequence fused with the luciferase sequence in the presence or absence of the IRES and the 30 UTR. The names,
the genomic organization of the plasmids and the nucleotide limits are indicated on the panels. Black arrows indicate the position of the primers
(Forward 1 and 2, Reverse 1) used for RT-PCR of HCV-luc transcripts. (C) Potential proteins resulting from each type of plasmid translation in the
0 and +1 frames (core in black, ARFP in grey, and luciferase in white).
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as recently described (4).
Luciferase assay
At 48h post-transfection, cells were washed twice in PBS
and lysed in 250ml Reporter Lysis Buﬀer (Promega).
Luciferase expression was determined using a TD-20/20
Luminometer (Turner Design). Brieﬂy, 5ml of cell lysate
were mixed with 25ml of Luciferase Reagent (Promega),
and luciferase activity was assessed as described by the
manufacturer. Each transfection or infection was per-
formed in triplicate and repeated at least three times. Each
set of experiments was normalized to the luciferase activity
in cells transfected by a control plasmid encoding the
luciferase gene in the absence of the HCV sequence
(pIV1066).
Western blot analysis
Huh-7 cells were lysed in Reporter Lysis Buﬀer (Promega).
The lysates were subjected to low-speed centrifugation
(500 g; 15s) to remove nuclei and debris. Proteins were
thenresolvedbySDS–PAGE,transblottedontoHybond-P
membranes (GE Healthcare), and probed with anti-
luciferase Mab (Sigma, dilution 1/500 in PBS, 0.1%
Tween; 1% skimmed milk) for 1h at room temperature.
After extensive washing, an anti-mouse IgG conjugated to
horseradish peroxidase (Sigma, diluted to 1/5000 in PBS,
0.1% Tween, 1% skimmed milk) was added to the blots for
1h at room temperature. Following an additional wash
step, the bound antibodies were detected by chemilumines-
cence (GE Healthcare).
RESULTS
Mapping of HCV genetic elements required
forARFP synthesis
Since ribosomal frameshifting eﬃciency can be optimized
by speciﬁc RNA structures, we evaluated the impact of
the RNA context on core/ARFP translation eﬃciency.
To address this question, we fused nts 342–822 of the core
protein coding sequence to a luciferase reporter gene
cDNA. We assessed translation eﬃciency in the three
frames (0, +1,  1) by adding zero, one or two nucleotides,
respectively, between the core protein and luciferase
sequences. To study the impact of HCV IRES on ARFP
translation a second set of similar plasmids lacking the
IRES element was constructed (Figure 1). The chimeric
HCV-luciferase reporter plasmids were transfected into
Huh-7 cells. To exclude translation initiation at the luci-
ferase AUG, the ﬁrst nine nucleotides, including the ATG,
were deleted in all HCV chimeric luciferase constructs.
Thus, for each plasmid, luciferase activity represented
translation of the respective frame. The normalization of
luciferase values, for each experiment and between diﬀer-
ent experiments, was performed using transfections with
pIV1066 control plasmid lacking HCV sequences.
Translation of the core protein-encoding sequence cor-
responding to the full-length ARF sequence (nts 342–822)
was analyzed by transfection of the HCV-Luc chimeric
constructs into Huh-7 hepatoma cells. Compared to
translation in the 0 frame (core-luc), a signiﬁcant level of
translation in the +1 frame (ARFP-luc) was observed as
shown in Figure 2. The translation ratio ARFP-luc/core-
luc was higher when the IRES was absent (compare 45/
251 RLU in Figure 2A and 62/94 RLU in Figure 2B).
These results clearly show that ARFP translation is not
dependent on the presence of the IRES. Luciferase activity
was absent in cells transfected with the  1 fusion
constructs. These data conﬁrm that translation in the
+1 frame, although occurring at low levels, was present
(Figure 2). Addition of the proteasome inhibitor MG132
did not modify translation eﬃciency (data not shown),
suggesting that diﬀerences in protein expression levels
were not due to diﬀerences in proteaosomal degradation
of HCV-luc fusion proteins.
We next investigated the impact of the HCV 30 UTR on
ARFP translation. Viral 30 regions have been shown to
enhance translation and replication. Furthermore, this
region has been shown to play a potential role in HCV
genome stabilization and/or encapsidation (28). The HCV
30 UTR consists of three regions: a variable sequence, an
internal poly (U/UC) stretch and the conserved X region.
The poly (U/UC) tail and the highly structured and
conserved X region are essential for replication in the
chimpanzee (29,30). Furthermore, the requirement of the
HCV 30 UTR for core protein translation has been
recently demonstrated (31,32). To study whether the 30
UTR has an impact on core/ARFP translation, we added
the HCV 30 UTR sequence downstream of the luciferase
gene coding sequence in plasmids containing the full-
length ARF sequence (nts 342–822) (Figure 1). Prior to
transfection into Huh-7 cells, plasmids were linearized
following the 30 UTR sequence to generate blunt-ended
extremities similar to the authentic HCV RNA. As shown
in Figure 2, the addition of the 30 UTR had no eﬀect on
IRES-mediated core-luc synthesis (Figure 2A, compare
pIV1143, 251 RLU and pIV1243, 276 RLU). Taken
together, these results show that the 30 UTR has no eﬀect
on IRES-mediated core-luc translation as previously
shown (25). The addition of the HCV 30 UTR induced
only a minor decrease in the +1 frame translation,
suggesting that this HCV genetic element is not required
for ARFP translation (Figure 2B).
Finally, we investigated the integrity of the RNA tran-
scripts by performing a RT-PCR of transcripts derived
from the luciferase reporter constructs in Huh-7 trans-
fected cells. The reverse transcriptase product was ampli-
ﬁed using a forward primer corresponding to the HCV
50 UTR for IRES-containing plasmids (Forward 1,
Figure 1A) or to the 50 region of the core protein encoding
gene for plasmids without IRES (Forward 2, Figure 1A),
and a reverse primer corresponding to the 30 part of the
luciferase gene (Reverse 1, Figure 1A). The expected size
of the corresponding RT-PCR products was 2.2kb in
constructs containing the HCV IRES and 1.8kb in
constructs without IRES. As shown in Figure 2C and D,
analysis of the corresponding ampliﬁed RT-PCR products
demonstrates the perfect integrity of all transcript tem-
plates. No signal was detected in cells transfected with
a control plasmid (pIV1066) or mock transfected cells.
Nucleic Acids Research, 2008, Vol. 36, No. 9 3057These data clearly rule out the possibility of cryptic
promoters, splicing or other events.
Taken together, these data demonstrate that ARFP
translation is not dependent on the presence of HCV
IRES and 30UTR.
Translationof ARFP in the+1 frame occurs
byalternative initiation
In our model, translation in the +1 frame can account for
diﬀerent fusion proteins: 26ARFP-luc and 86/88ARFP-luc
as well as fARFP-luc. Indeed, since the translation machin-
ery can recognize the core AUG (0 frame) even in the
absence of the IRES sequence (compare pIV1143
Figure 2A with pIV1145 Figure 2B), the possibility of a
ribosomal frameshifting or a transcriptional slippage event
cannot be excluded.
To distinguish ribosomal frameshifting or transcrip-
tional slippage from alternative initiation of translation,
we suppressed fARFP synthesis. Using site-directed muta-
genesis, a stop codon in the ARF-coding sequence at
Figure 2. Translation of chimeric HCV core-luciferase sequences in frames 0, +1 and  1 in hepatoma cells. Plasmids containing nts 342–822 of the
core coding sequence fused to a luciferase gene reporter cDNA were transfected into Huh-7 cells. The translation of HCV 50 sequences was studied in
the three frames [0 (core frame) in black, +1 (ARFP frame) in gray and  1 frame in white] and in the presence (A) or absence (B) of the IRES
sequence, using luciferase activity quantiﬁcation. The integrity of the RNA transcripts was investigated in Huh-7 cells transfected with HCV-luc
plasmids containing the IRES (C) or lacking the IRES (D). RT-PCR of HCV-luc transcripts. Total RNA was puriﬁed from Huh-7 cells transfected
with the indicated plasmids and reverse transcribed as described earlier. The resulting cDNAs were ampliﬁed by PCR using HCV (Forward 1 and 2)
and Luc-speciﬁc primers (Reverse 1, see Figure 1A for primer position). Plasmid pIV1066 encoding luciferase and Huh-7 cells transfected with an
irrelevant plasmid were used as controls.
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 S22) was introduced (Figure 3A). The muta-
tion of the ARFP codon 22 into
 S22 stop codon does
not modify the core protein amino acid sequence but
terminates fARFP-luc protein synthesis at codon 22
(Figure 3B). To demonstrate that the
 S22 (ARFP) stop
mutation had no impact at the core-luc protein transla-
tion level, we measured the core-luc (0 frame) translation
rates of transfected
 S22 ‘0’ frame fusion plasmids and
compared those rates to those of regular 0 frame trans-
fected plasmids. As expected, core-luc protein translation
(frame 0) was not aﬀected by the
 S22 stop mutation
(Figure 3C).
To determine the fraction of +1 frame translation
that results from alternative initiation of translation,
we transfected
 S22 +1 frame fusion plasmids into Huh-7
cells (Figure 3A). Using these reporter constructs,
we detected signiﬁcant translation in the +1 frame
(Figure 3C). The luciferase expression measured in these
constructs, accounts for alternative initiation of translation
on codon 26 (26ARFP) and/or codon 86/88 (86/88ARFP) in
the +1 frame, but not for fARFP. The alternative initia-
tion of translation measured corresponded to 50% of the
regular non mutated +1 frame translation. Therefore,
our experiments demonstrate that translation occurring
in the +1 frame is mediated at least in a large part by
alternative initiation of translation occurring downstream
of the
 S22 stop codon introduced in the ARFP coding-
sequence.
Figure 3. Alternative initiation of ARFP translation in the +1 frame. (A) Plasmid constructs containing the
 S22 stop codon mutation in the +1
frame resulting in knock-out of fARFP expression. Plasmid numbers are indicated. (B) Potential proteins resulting from translation in the 0 and +1
frames. (C) Huh-7 cells were transfected with the constructs shown in (A) and luciferase activity was assessed as described above. Black and grey bars
correspond to HCV translation in the 0 and +1 frame, respectively.
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in prototype isolate HCV H77 (frameshifting or trans-
criptional slippage versus alternative internal initiation),
we characterized translation products synthesized in the
+1 frame in Huh-7 cells transfected with recombinant
plasmids containing the HCV H77 ARFP coding sequence
(nts 342–822). Since monoclonal anti-ARFP antibodies
directed against epitopes of the ARFP N-terminal domain
are unavailable, ARFP-luc fusion proteins were analyzed
using an anti-luc monoclonal antibody. Expected fusion
protein sizes were 60kDa for luciferase, 78kDa for the
core/fARFP-luc fusion proteins and 75 and 68kDa for
fusion proteins synthesized by alternative initiation at
positions 26 (26ARFP-luc) and 86/88 (86/88ARFP-luc),
respectively. Background translation of luciferase in the
fusion constructs was minimal, compared to expression of
the fusion proteins (Figure 4, lanes 4 and 5). The two
forms detected for ARFP synthesis corresponded to
products derived from alternative initiation sites: the
major band corresponded to 86/88ARFP, whereas 26ARFP
was synthesized at a lower level (Figure 4). In our
experimental system, fARFP was not detected. Since the
addition of proteasome inhibitor MG-132 did not modify
protein expression (data not shown), it is likely that the
absence of fARFP detection was not due to a problem
with protein stability.
Thus, we conclude that the observed +1 frame (ARFP-
luc) translation occurs from alternative initiation of trans-
lation. The decrease in ARFP-luc translation observed in
the
 S22-mutated constructs (Figure 3C) is likely the result
of a decrease in alternative initiation of translation at
position 26, due to the
 S22 mutation itself, rather than a
suppression of a putative ribosomal frameshifting event.
Regulation of ARFP alternative initiation by HCV core
proteinexpression
Core protein is known to play a role in HCV polyprotein
translation. It has been shown to decrease the translation
activity of the IRES through interactions involving
50 regions (33). Whether this inhibition depends on
RNA–RNA (34,35) or core-RNA interactions (36,37)
remains unclear. Thus, we aimed to study whether core
protein plays a role in the regulation of ARFP translation.
First, we investigated the impact of core protein on the
+1 frame translation in cis. To address this question, we
constructed plasmids containing a stop codon (
 Q20) in the
core-encoding sequence fused in the +1 frame to the luc
gene (Figure 5A). In these plasmids, core protein is not
synthesized, whereas ARFP translation is maintained.
Interestingly, in the absence of the core protein, we
observed a marked, 4-fold enhancement of ARFP-luc
fusion protein expression in the +1 frame (Figure 5C,
compare black and white bars). Thus, the premature stop
of core protein translation at codon 20 in the 0 frame
resulted in a marked increase of ARFP synthesis. This
observation suggested a negative regulation of core
protein on ARFP synthesis. Moreover, the core protein
inhibitory eﬀect was corroborated by Western blot
analysis of the expressed proteins. As shown in Figure 4,
the expression of 86/88ARFP-luc fusion protein (pIV1204,
lane 5) was markedly increased in Huh-7 cells transfected
with plasmids containing the
 Q20 core stop mutation,
compared to plasmids allowing core protein expression in
cis (pIV1144, lane 4). Thus, when core protein translation
was absent (pIV1204, lane 5), 86/88ARFP represented the
major ARFP translation product.
To conﬁrm the negative regulation of ARFP translation
by core protein, we studied the impact of core protein
expressed in trans on ARFP synthesis. To ensure that core
protein was expressed in the entire transfected cell popu-
lation, we constructed a recombinant adenovirus encod-
ing the full-length core protein (Ad core). As a control,
we used an adenovirus encoding the green ﬂuorescent
protein (Ad control).
To test the hypothesis of a direct eﬀect of core protein
expression on ARFP translation, we infected Huh-7 cells
transfected with the plasmids containing the
 Q20 stop
mutation with the core-encoding recombinant adenovirus
(Ad core). The impact of the adenovirus on translation of
these plasmids was ﬁrst evaluated by using the GFP-
encoding adenovirus as a control. The control adenovirus
induced a global enhancement of translation (Figure 5C
and D). However, expression of core in trans by the
recombinant adenovirus (Ad core) decreased the +1
frame (ARFP-luc) translation to levels similar to those
obtained with non-mutated core-encoding plasmids
(Figure 5C and D). Since translation in the +1 frame
was enhanced in the absence of core protein and was
markedly reduced when core protein is added in trans,w e
conclude that core protein expression has an inhibitory
eﬀect on ARFP synthesis.
DISCUSSION
It has been suggested that the core protein encoding
sequence directs the synthesis of three diﬀerent products:
(i) the core protein in the 0 frame, (ii) the ARFP in the +1
frame and (iii) a 13 amino-acid peptide in the  1 frame (5).
The ARFP itself can result from a +1 ribosomal
Figure 4. Identiﬁcation of luciferase fusion proteins. Lysates of Huh-7
cells transfected with the luciferase encoding plasmid (pIV1066, lane 1),
the empty pCI-neo vector (mock, lane 2), plasmids containing
sequences encoding core-luc (pIV1143, lane 3), ARF-luc (pIV1144,
lane 4) or ARF-luc containing the
 Q20 core mutation (pIV1204, lane 5)
were analyzed by Western blotting using an anti-luciferase monoclonal
antibody as described in ‘Material and methods’ section. Identiﬁed
translation products are indicated on the right of the panel.
3060 Nucleic Acids Research, 2008, Vol. 36, No. 9frameshifting event (6) (fARFP) and/or alternative
initiation in the +1 frame at codon 26 (23) (26ARFP)
and 86/88 (24) (86/88ARFP). In addition, a transcriptional
slippage event cannot be excluded. To compare the
translation levels of these proteins, we designed plasmids
containing the HCV core/ARFP sequence fused in the 0,
+1 or  1 frame to a luciferase reporter gene cDNA. Using
hepatoma cells transfected with chimeric HCV-luciferase
Figure 5. Regulation of ARFP translation by HCV core protein. (A) Plasmids containing a stop codon in the 0 frame (
 Q20). Names of the plasmids are
indicated on the panel. (B) Proteins resulting from plasmid expression in the 0 and +1 frames of constructs lacking the core ORF. (C) To study the eﬀect
of core in cis, we transfected cells with +1 frame constructs with or without the
 Q20 mutation. Luciferase activity corresponds to the translation in the
+1 frame without mutation (black bars) and with the
 Q20 stop mutation (white bars). (D) To study the eﬀect of core in trans, cells were transfected with
+1 frame constructs containing the
 Q20 mutation and transduced with a control adenovirus (Ad control, white bars) or a HCV core-encoding
adenovirus (Ad core, hatched bars). Luciferase activity was analyzed in the presence or absence of the HCV IRES as described earlier.
Nucleic Acids Research, 2008, Vol. 36, No. 9 3061reporter constructs as a model system, we demonstrate
that the predominant form of ARFP is a 70 amino acid
protein initiated at codon 86/88. Finally, we show that
core protein regulates ARFP synthesis by inhibiting
86/88ARFP translation.
Evidence for a +1 ribosomal frameshifting event was
demonstrated in vitro by Xu et al. (6) using a unique
sequence of genotype 1a containing a 10-adenine stretch in
the ﬁrst 50nt of the core protein coding sequence (6).
However, the incidence of this A stretch appears to be
very rare since only a single HCV sequence of this type
is found in the European HCV database (http://
euhcvdb.ibcp.fr/) (38). Thus, conclusions derived from
translation studies using this unique sequence may not
generally apply for other, more prevalent HCV strains. To
study mechanisms of ARFP translation in well character-
ized infectious and functional HCV strains, we used
prototype infectious clone HCV H77 (39). Analysis of the
translation products of HCV H77 luc plasmids (Figure 4)
clearly demonstrates that ARFP synthesis in the HCV
H77 strain occurs by alternative internal initiation of
translation.
The IRES-independence of the ARFP translation could
be related to the nature of codon GUG at position 26 in
the HCV genotype 1a sequence that we used. Indeed, in a
recent report, Baril and Brakier-Gingras (23) showed that
the ARFP translation is IRES independent when a GUG
codon is present at position 26, which is the case in the 1a
genotype (23). Besides IRES-independence, the mecha-
nism responsible for initiation at codon 26 and/or 86/88
remains to be determined. Although our results cannot
exclude a linear scanning event, such a mechanism seems
to be highly unlikely in the presence of the IRES because
of the stability of its structure. At least two other
alternative mechanisms could explain the recruitment of
ribosomal subunits far upstream of the initiation codon:
ﬁrst, internal initiation could occur through an internal
ribosome entry site present in the viral sequence down-
stream of the HCV IRES; second, speciﬁc ribosomal
shunting or ribosomal tethering and clustering (40) could
be involved in initiation of ARFP translation. The latter
model is highly interesting because it explains how
translation can initiate on AUG codons located either
downstream or upstream of an IRES. According to this
hypothesis, ARFP translation would be dependent on an
IRES located downstream of codon 86/88.
The addition of the HCV 30 UTR induced only a
minimal decrease in translation in the 0 or +1 frame,
suggesting that this HCV genetic element is not required
for ARFP translation. Nevertheless, the HCV-luc model
system is limited to the ARFP and core protein coding
sequences. Thus, we cannot exclude that results might be
diﬀerent using a full-length infectious clone as a model
system. However, the diﬃculty studying translation of the
short +1 frame protein in the full-length clone currently
precludes the use of this system to address this question.
Most importantly, we demonstrate that HCV core
protein plays a key role in the regulation of 86/88ARFP
translation in HCV target cells. Using a stop muta-
tion preventing core protein expression, we demon-
strate that core protein inhibits 86/88ARFP synthesis.
Furthermore, inhibition of ARFP synthesis can be restored
by expression of core protein in trans. Since the two
proteins partially share the same RNA sequence, a switch
between ARFP and core protein translation can be
imagined during the viral cycle. Core protein is the capsid
protein. Its level may vary during the viral life cycle (i.e.
during encapsidation), allowing a modiﬁcation of ARFP
translation eﬃciency. ARFP could also be synthesized
when core protein is expressed at a lower rate, i.e. during
the very early or the late phase of chronic infection, when
levels of viral replication can be low. Suppression of ARFP
translation by HCV core protein suggests that ARFP
expression is inversely linked to viral replication. Further-
more, these ﬁndings may explain the apparent low-level
expression of ARFP during viral infection, precluding its
easy detection during HCV infection in vivo or in vitro.
Core-mediated regulation of ARFP translation may
have important implications for the role of ARFP in the
viral cycle. The interaction of core protein with its RNA
coding sequence has been described (33). Thus, ARFP
translation may be silenced in the presence of core protein
bound to RNA, and this inhibition is reversed when core
protein is expressed at low levels or is channeled into
nucleocapsid assembly.
It is conceivable that the observed inhibition of ARFP
expression by core protein may also play an important
role in suppressing the putative ARFP function. Such a
mechanism could result in the establishment of a stoichio-
metric balance between ARFP and core protein, reminis-
cent of translation regulation in HIV, where Env protein
expression is high and related to a weak Vpu protein
synthesis (41).
The impact of the ARFP role in the viral cycle is still
unknown. Since the existence of an additional protein in
an alternate reading frame has not yet been described for
other members of the Flaviviridae family, we looked for
the presence of similar proteins in other virus families.
Similar to HCV, the translation of picornaviruses is IRES-
dependent, resulting in the synthesis of a polyprotein
cleaved into structural and non-structural proteins. For
encephalomyocarditis virus (EMCV), foot and mouth
disease virus (FMDV), hepatitis A virus and Theiler’s
murine encephalomyelitis virus (TMEV), additional initia-
tion sites exist in the same frame and have been
documented in vitro (EMCV, hepatitis A and FMDV)
(42–44) and in vivo (FMDV) (44). Initiation sites for L
 
protein in the +1 frame both in vitro and in vivo have been
identiﬁed for TMEV (45). The TMEV L
  out-of-frame
protein was ﬁrst thought to be an artifact of in vitro
translation. However, more recent studies indicate that
this protein indeed has an anti-apoptotic activity and is
involved in viral pathogenesis and persistence (46). Thus,
it is conceivable that ARFP may also play a functional
role in the HCV viral life cycle. Although a recent study
has demonstrated that ARFP may not be required for
viral replication (47), the constructs used in the latter
study (47) did not prevent expression of 86/88ARFP. Thus,
a functional role for 86/88ARFP in viral replication is still
conceivable. Interestingly, HCV-infected patients mount
an easily detectable, humoral immune response against
ARFP, suggesting that this protein is expressed in vivo.
3062 Nucleic Acids Research, 2008, Vol. 36, No. 9The short protein half-life of about 10min (10,11) could
point to a punctual action during the viral cycle.
In conclusion, suppression of ARFP expression by core
protein suggests that ARFP expression is inversely linked
to viral replication. The identiﬁcation of negative regula-
tion by HCV core protein expression may set the stage for
further studies addressing the function of 86/88ARFP
within the viral life cycle and the pathogenesis of HCV
infection.
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